LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Toby Gish <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Mon, 15 May 2006 10:03:40 +0200
Content-Type:
text/plain
Parts/Attachments:
text/plain (31 lines)
http://apnews.excite.com/article/20060514/D8HJR2LG0.html

Biotech Firm Raises Furor With Rice Plan


May 14, 6:37 PM (ET)

By PAUL ELIAS 

SAN FRANCISCO (AP) - A tiny biosciences company is developing a promising drug to fight diarrhea, a scourge among babies in the developing world, but it has made an astonishing number of powerful enemies because it grows the experimental drug in rice genetically engineered with a human gene...............................



..............Ventria's rice produces two human proteins found in mother's milk, saliva and tears, which help people hydrate and lessen the severity and duration of diarrhea attacks, a top killer of children in developing countries.



Sent without comment. Toby Gish RN, IBCLC (Haifa, Israel) Private Practice

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2